Almac puts $20M into U.S., U.K. operations; Novasep's labs pass FDA muster;

> Almac is spending $20 million to grow its commercial offerings in the U.S. and U.K. News

> Harlan Contract Research Services has expanded its ranks in pathology. More

> Novasep's French and German contract manufacturing sites have passed FDA inspection, the company said. Item

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.